Amy Huebschmann
Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 17 | 2023 | 2582 | 1.750 |
Why?
| | Primary Health Care | 17 | 2026 | 1734 | 1.710 |
Why?
| | Exercise | 15 | 2025 | 2192 | 1.710 |
Why?
| | School Health Services | 4 | 2024 | 221 | 1.700 |
Why?
| | Asthma | 5 | 2024 | 1795 | 1.490 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 167 | 1.000 |
Why?
| | Qualitative Research | 9 | 2026 | 1677 | 0.990 |
Why?
| | Cancer Survivors | 3 | 2026 | 336 | 0.950 |
Why?
| | Contraception | 2 | 2021 | 170 | 0.940 |
Why?
| | Mass Screening | 7 | 2026 | 1358 | 0.930 |
Why?
| | Harm Reduction | 1 | 2025 | 50 | 0.880 |
Why?
| | Health Equity | 2 | 2025 | 133 | 0.880 |
Why?
| | Community Participation | 1 | 2025 | 123 | 0.840 |
Why?
| | Community-Institutional Relations | 1 | 2025 | 100 | 0.840 |
Why?
| | Telemedicine | 3 | 2025 | 960 | 0.800 |
Why?
| | School Nursing | 1 | 2024 | 33 | 0.790 |
Why?
| | Chest Pain | 1 | 2024 | 100 | 0.790 |
Why?
| | Program Development | 1 | 2025 | 369 | 0.780 |
Why?
| | Diabetes Mellitus | 5 | 2020 | 1076 | 0.760 |
Why?
| | Motivation | 2 | 2018 | 602 | 0.720 |
Why?
| | Exercise Therapy | 2 | 2026 | 476 | 0.700 |
Why?
| | Hospice Care | 1 | 2025 | 226 | 0.690 |
Why?
| | Humans | 77 | 2026 | 145491 | 0.680 |
Why?
| | Cardiovascular Diseases | 5 | 2023 | 2185 | 0.680 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1755 | 0.650 |
Why?
| | Referral and Consultation | 2 | 2026 | 862 | 0.630 |
Why?
| | Mentoring | 2 | 2024 | 165 | 0.620 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 482 | 0.610 |
Why?
| | Self-Management | 2 | 2019 | 201 | 0.610 |
Why?
| | Couples Therapy | 1 | 2019 | 13 | 0.610 |
Why?
| | Counseling | 2 | 2014 | 405 | 0.600 |
Why?
| | Research Design | 4 | 2022 | 1134 | 0.600 |
Why?
| | Health Behavior | 4 | 2024 | 788 | 0.560 |
Why?
| | Postpartum Period | 1 | 2021 | 373 | 0.550 |
Why?
| | Female | 44 | 2026 | 78763 | 0.540 |
Why?
| | Information Dissemination | 2 | 2023 | 224 | 0.530 |
Why?
| | Health Promotion | 4 | 2025 | 775 | 0.520 |
Why?
| | Aged | 25 | 2026 | 26125 | 0.510 |
Why?
| | Interviews as Topic | 5 | 2026 | 909 | 0.500 |
Why?
| | Sex Factors | 5 | 2024 | 2110 | 0.500 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1097 | 0.470 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3424 | 0.460 |
Why?
| | Hair | 1 | 2015 | 86 | 0.440 |
Why?
| | Male | 36 | 2026 | 72817 | 0.440 |
Why?
| | Surveys and Questionnaires | 11 | 2025 | 6070 | 0.420 |
Why?
| | Patients | 3 | 2020 | 182 | 0.410 |
Why?
| | Athletes | 1 | 2018 | 421 | 0.410 |
Why?
| | Program Evaluation | 4 | 2026 | 945 | 0.410 |
Why?
| | Social Determinants of Health | 4 | 2024 | 308 | 0.410 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1417 | 0.400 |
Why?
| | Caregivers | 5 | 2024 | 1070 | 0.390 |
Why?
| | Biomarkers | 1 | 2024 | 4283 | 0.380 |
Why?
| | Professional-Patient Relations | 2 | 2012 | 154 | 0.380 |
Why?
| | Needs Assessment | 3 | 2024 | 401 | 0.380 |
Why?
| | Delivery of Health Care | 5 | 2022 | 948 | 0.370 |
Why?
| | Colorado | 8 | 2025 | 4572 | 0.370 |
Why?
| | Healthcare Disparities | 2 | 2025 | 739 | 0.360 |
Why?
| | Hypertension | 4 | 2022 | 1273 | 0.360 |
Why?
| | Biomedical Research | 1 | 2019 | 718 | 0.360 |
Why?
| | Peer Group | 2 | 2025 | 258 | 0.350 |
Why?
| | Middle Aged | 26 | 2025 | 36176 | 0.350 |
Why?
| | Aging, Premature | 1 | 2011 | 16 | 0.350 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2664 | 0.350 |
Why?
| | Home Care Services | 2 | 2025 | 282 | 0.330 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2024 | 133 | 0.330 |
Why?
| | Critical Pathways | 1 | 2012 | 108 | 0.320 |
Why?
| | Neoplasms | 1 | 2026 | 2897 | 0.320 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 271 | 0.320 |
Why?
| | Patient Preference | 2 | 2024 | 226 | 0.310 |
Why?
| | Dietary Fats | 1 | 2012 | 308 | 0.300 |
Why?
| | Health Personnel | 3 | 2025 | 750 | 0.290 |
Why?
| | Perception | 2 | 2024 | 378 | 0.290 |
Why?
| | Disease Management | 2 | 2015 | 654 | 0.280 |
Why?
| | Occupational Health | 2 | 2022 | 211 | 0.280 |
Why?
| | Physical Exertion | 1 | 2009 | 205 | 0.280 |
Why?
| | Medicare | 4 | 2022 | 905 | 0.280 |
Why?
| | Adult | 25 | 2025 | 40707 | 0.280 |
Why?
| | Feasibility Studies | 3 | 2022 | 1119 | 0.270 |
Why?
| | Diabetic Angiopathies | 3 | 2017 | 263 | 0.270 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1369 | 0.270 |
Why?
| | Fear | 1 | 2011 | 367 | 0.260 |
Why?
| | Attitude of Health Personnel | 2 | 2024 | 1188 | 0.260 |
Why?
| | Palliative Care | 3 | 2025 | 1017 | 0.260 |
Why?
| | Heart Failure | 4 | 2025 | 2329 | 0.250 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 884 | 0.240 |
Why?
| | Electronic Health Records | 3 | 2025 | 1187 | 0.240 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 41 | 0.230 |
Why?
| | Social Support | 3 | 2024 | 651 | 0.230 |
Why?
| | Vascular Stiffness | 2 | 2023 | 486 | 0.220 |
Why?
| | Physicians | 3 | 2023 | 952 | 0.220 |
Why?
| | Chronic Disease | 4 | 2024 | 1816 | 0.220 |
Why?
| | United States | 11 | 2025 | 16115 | 0.210 |
Why?
| | Adolescent | 10 | 2024 | 22485 | 0.210 |
Why?
| | Troponin | 1 | 2024 | 50 | 0.210 |
Why?
| | Delirium | 1 | 2026 | 105 | 0.210 |
Why?
| | Troponin T | 1 | 2024 | 63 | 0.210 |
Why?
| | Aged, 80 and over | 4 | 2025 | 8326 | 0.210 |
Why?
| | Point-of-Care Systems | 2 | 2020 | 188 | 0.210 |
Why?
| | Troponin I | 1 | 2024 | 73 | 0.200 |
Why?
| | Narration | 1 | 2024 | 79 | 0.200 |
Why?
| | Transportation | 1 | 2024 | 56 | 0.200 |
Why?
| | Social Isolation | 1 | 2024 | 73 | 0.190 |
Why?
| | Vulnerable Populations | 1 | 2024 | 175 | 0.190 |
Why?
| | Pilot Projects | 4 | 2025 | 1896 | 0.180 |
Why?
| | Oxygen | 2 | 2018 | 986 | 0.180 |
Why?
| | Mental Health | 3 | 2024 | 795 | 0.180 |
Why?
| | Cross-Sectional Studies | 8 | 2021 | 5891 | 0.180 |
Why?
| | Advance Care Planning | 1 | 2025 | 244 | 0.170 |
Why?
| | Breast Neoplasms | 2 | 2025 | 2373 | 0.170 |
Why?
| | Patient Care Team | 3 | 2025 | 696 | 0.170 |
Why?
| | Leg | 2 | 2021 | 244 | 0.170 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2023 | 115 | 0.170 |
Why?
| | Government Programs | 1 | 2021 | 27 | 0.170 |
Why?
| | Health Care Surveys | 2 | 2014 | 538 | 0.170 |
Why?
| | Mental Health Services | 2 | 2025 | 472 | 0.170 |
Why?
| | Child | 9 | 2024 | 22680 | 0.170 |
Why?
| | Psychometrics | 1 | 2025 | 731 | 0.160 |
Why?
| | Contraceptive Agents | 1 | 2021 | 65 | 0.160 |
Why?
| | Oxygen Consumption | 6 | 2021 | 718 | 0.160 |
Why?
| | Ambulatory Care | 1 | 2025 | 608 | 0.160 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 209 | 0.160 |
Why?
| | Multiple Chronic Conditions | 1 | 2020 | 34 | 0.160 |
Why?
| | Guatemala | 1 | 2021 | 344 | 0.150 |
Why?
| | Influenza Vaccines | 1 | 2024 | 533 | 0.150 |
Why?
| | Social Welfare | 1 | 2019 | 27 | 0.150 |
Why?
| | Precision Medicine | 1 | 2024 | 456 | 0.150 |
Why?
| | Community Mental Health Services | 1 | 2020 | 86 | 0.150 |
Why?
| | Social Work | 1 | 2020 | 85 | 0.150 |
Why?
| | Patient Navigation | 1 | 2022 | 126 | 0.150 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 16 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 470 | 0.150 |
Why?
| | Sitagliptin Phosphate | 1 | 2019 | 31 | 0.150 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 92 | 0.150 |
Why?
| | Socioeconomic Factors | 2 | 2015 | 1327 | 0.150 |
Why?
| | Dementia | 1 | 2023 | 325 | 0.140 |
Why?
| | Diastole | 1 | 2019 | 146 | 0.140 |
Why?
| | Patient Care Planning | 1 | 2020 | 170 | 0.140 |
Why?
| | Schools | 1 | 2022 | 453 | 0.140 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 46 | 0.140 |
Why?
| | Accelerometry | 1 | 2019 | 118 | 0.140 |
Why?
| | Influenza, Human | 1 | 2024 | 623 | 0.140 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 74 | 0.140 |
Why?
| | Inpatients | 1 | 2023 | 550 | 0.140 |
Why?
| | Exercise Tolerance | 2 | 2017 | 283 | 0.130 |
Why?
| | Quality Improvement | 2 | 2026 | 1294 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2019 | 137 | 0.130 |
Why?
| | Cultural Characteristics | 1 | 2018 | 69 | 0.130 |
Why?
| | Focus Groups | 2 | 2023 | 569 | 0.130 |
Why?
| | Emergency Service, Hospital | 3 | 2026 | 2379 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1242 | 0.130 |
Why?
| | Checklist | 1 | 2018 | 111 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 427 | 0.120 |
Why?
| | Venoms | 1 | 2016 | 22 | 0.120 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 120 | 0.120 |
Why?
| | Ultrasonography | 1 | 2020 | 784 | 0.120 |
Why?
| | Patient Satisfaction | 2 | 2019 | 710 | 0.120 |
Why?
| | Health Services Accessibility | 2 | 2024 | 1101 | 0.120 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2016 | 34 | 0.120 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1392 | 0.120 |
Why?
| | Research Personnel | 1 | 2018 | 187 | 0.120 |
Why?
| | Vaccination | 1 | 2024 | 1423 | 0.120 |
Why?
| | Self Efficacy | 1 | 2019 | 409 | 0.120 |
Why?
| | Microvessels | 1 | 2017 | 98 | 0.120 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1794 | 0.120 |
Why?
| | Blood Vessels | 1 | 2017 | 167 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 783 | 0.110 |
Why?
| | Sex Characteristics | 2 | 2022 | 779 | 0.110 |
Why?
| | American Heart Association | 1 | 2015 | 360 | 0.100 |
Why?
| | Risk Factors | 3 | 2020 | 10874 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 394 | 0.100 |
Why?
| | Faculty | 1 | 2014 | 153 | 0.090 |
Why?
| | Interprofessional Relations | 1 | 2015 | 275 | 0.090 |
Why?
| | Pandemics | 1 | 2021 | 1706 | 0.090 |
Why?
| | Incidence | 1 | 2019 | 2915 | 0.090 |
Why?
| | Attitude to Health | 1 | 2015 | 431 | 0.090 |
Why?
| | Prospective Studies | 3 | 2021 | 8039 | 0.090 |
Why?
| | Prevalence | 1 | 2019 | 2855 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2015 | 464 | 0.090 |
Why?
| | Pharmacists | 1 | 2015 | 259 | 0.090 |
Why?
| | Women's Health | 1 | 2014 | 308 | 0.090 |
Why?
| | Age Factors | 2 | 2025 | 3340 | 0.090 |
Why?
| | Internal Medicine | 1 | 2014 | 279 | 0.080 |
Why?
| | Stroke Volume | 2 | 2025 | 654 | 0.080 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 147 | 0.080 |
Why?
| | Exercise Test | 2 | 2015 | 628 | 0.080 |
Why?
| | Psychotherapy | 1 | 2012 | 190 | 0.080 |
Why?
| | Peptides | 1 | 2016 | 993 | 0.080 |
Why?
| | Antidepressive Agents | 1 | 2012 | 250 | 0.080 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.080 |
Why?
| | Health Expenditures | 1 | 2012 | 194 | 0.080 |
Why?
| | Nonprescription Drugs | 1 | 2010 | 69 | 0.080 |
Why?
| | Internet | 2 | 2025 | 701 | 0.070 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 267 | 0.070 |
Why?
| | Depressive Disorder | 1 | 2012 | 387 | 0.070 |
Why?
| | Workplace | 2 | 2022 | 272 | 0.070 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 170 | 0.070 |
Why?
| | Obesity | 2 | 2023 | 3076 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2014 | 775 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 518 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 587 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2030 | 0.070 |
Why?
| | Prejudice | 1 | 2007 | 61 | 0.060 |
Why?
| | Disclosure | 1 | 2007 | 84 | 0.060 |
Why?
| | Guideline Adherence | 1 | 2012 | 590 | 0.060 |
Why?
| | Diabetes, Gestational | 1 | 2011 | 308 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5426 | 0.060 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2006 | 29 | 0.060 |
Why?
| | Walking | 1 | 2011 | 542 | 0.060 |
Why?
| | Nebraska | 1 | 2025 | 21 | 0.060 |
Why?
| | Wyoming | 1 | 2025 | 27 | 0.060 |
Why?
| | Medicaid | 2 | 2019 | 466 | 0.060 |
Why?
| | Hypoglycemia | 1 | 2010 | 479 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 206 | 0.050 |
Why?
| | Mothers | 1 | 2011 | 767 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 411 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 2017 | 515 | 0.050 |
Why?
| | Safety-net Providers | 1 | 2024 | 129 | 0.050 |
Why?
| | Internship and Residency | 1 | 2014 | 1265 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2019 | 2060 | 0.050 |
Why?
| | Delphi Technique | 1 | 2024 | 333 | 0.050 |
Why?
| | Language | 1 | 2025 | 323 | 0.050 |
Why?
| | Cardiology | 1 | 2025 | 365 | 0.040 |
Why?
| | Patient Care | 1 | 2023 | 118 | 0.040 |
Why?
| | Longevity | 1 | 2022 | 175 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 286 | 0.040 |
Why?
| | Small Business | 1 | 2021 | 51 | 0.040 |
Why?
| | Point-of-Care Testing | 1 | 2020 | 35 | 0.040 |
Why?
| | Aging | 1 | 2011 | 1940 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 483 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 590 | 0.040 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 51 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 193 | 0.040 |
Why?
| | Self Care | 1 | 2022 | 389 | 0.040 |
Why?
| | Goals | 1 | 2020 | 185 | 0.030 |
Why?
| | Models, Biological | 1 | 2006 | 1815 | 0.030 |
Why?
| | Overweight | 1 | 2023 | 607 | 0.030 |
Why?
| | Poverty | 1 | 2022 | 525 | 0.030 |
Why?
| | Young Adult | 2 | 2012 | 14192 | 0.030 |
Why?
| | Cell Respiration | 1 | 2018 | 105 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 97 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2022 | 570 | 0.030 |
Why?
| | Capillary Resistance | 1 | 2017 | 4 | 0.030 |
Why?
| | Oxyhemoglobins | 1 | 2017 | 28 | 0.030 |
Why?
| | Publishing | 1 | 2018 | 115 | 0.030 |
Why?
| | Cognition | 1 | 2025 | 1268 | 0.030 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2017 | 70 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 11831 | 0.030 |
Why?
| | Microcirculation | 1 | 2017 | 142 | 0.030 |
Why?
| | Bicycling | 1 | 2017 | 117 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 836 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2017 | 369 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2025 | 17269 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2016 | 147 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1404 | 0.030 |
Why?
| | Communication | 1 | 2022 | 975 | 0.030 |
Why?
| | Infant | 2 | 2024 | 10064 | 0.030 |
Why?
| | Ventricular Function | 1 | 2015 | 54 | 0.030 |
Why?
| | Arteries | 1 | 2016 | 261 | 0.030 |
Why?
| | Hemoglobins | 1 | 2017 | 386 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1157 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 119 | 0.030 |
Why?
| | Forearm | 1 | 2015 | 141 | 0.030 |
Why?
| | Blood Pressure | 1 | 2021 | 1782 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 114 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 218 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1350 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11837 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2950 | 0.020 |
Why?
| | Brachial Artery | 1 | 2015 | 208 | 0.020 |
Why?
| | Reaction Time | 1 | 2015 | 438 | 0.020 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 43 | 0.020 |
Why?
| | Pediatrics | 1 | 2020 | 1121 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2016 | 754 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 521 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1605 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3195 | 0.020 |
Why?
| | Mexico | 1 | 2011 | 234 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3759 | 0.020 |
Why?
| | Computer Communication Networks | 1 | 2010 | 32 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 951 | 0.020 |
Why?
| | Blood Glucose | 1 | 2019 | 2330 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2011 | 158 | 0.020 |
Why?
| | Comorbidity | 1 | 2012 | 1659 | 0.020 |
Why?
| | Public Opinion | 1 | 2007 | 62 | 0.020 |
Why?
| | Homosexuality, Female | 1 | 2007 | 42 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 639 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 2130 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 679 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1244 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 760 | 0.010 |
Why?
| | Homosexuality, Male | 1 | 2007 | 232 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 7197 | 0.010 |
Why?
|
|
Huebschmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|